Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Van Hul

Showing results (41-50 of 170) with videos related to

Pageof 17
Sort By:
American Journal of Medical Genetics. Part A|October 14, 2005
A novel mutation in the MSX2 gene in a family with foramina parietalia permagna (FPP)Liesbeth Spruijt, Pieter Verdyck, Wim Van Hul, et al.
The Journal of Biological Chemistry|December 21, 2002
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant proteinKatrien Janssens, Peter ten Dijke, Stuart H Ralston, et al.
Calcified Tissue International|November 25, 2019
WNT16 Requires Gα Subunits as Intracellular Partners for Both Its Canonical and Non-Canonical WNT Signalling Activity in OsteoblastsGretl Hendrickx, Eveline Boudin, Marinus Verbeek, et al.
Endocrine|April 29, 2009
Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variantsArmand Peeters, Sigri Beckers, An Verrijken, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 14, 2007
Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signalingWendy Balemans, Jean-Pierre Devogelaer, Erna Cleiren, et al.
Endocrine|October 26, 2010
Common melanocortin-3 receptor variants are not associated with obesity, although rs3746619 does influence weight in obese individualsDoreen Zegers, Sigri Beckers, Ilse L Mertens, et al.
Bone|April 9, 2013
No mutations in the serotonin related TPH1 and HTR1B genes in patients with monogenic sclerosing bone disordersEveline Boudin, Karen Jennes, Fenna de Freitas, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|October 23, 2008
Recurrent sclerosing dysplasia of bone: report of a caseMartin Druce Batstone, Gary Walton, Anthony Lynham, et al.
Molecular Genetics and Metabolism|April 5, 2011
Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in menDoreen Zegers, Sigri Beckers, Ilse L Mertens, et al.
Molecular and Cellular Biology|June 1, 2005
Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signalingMinrong Ai, Sheri L Holmen, Wim Van Hul, et al.
Pageof 17

Showing results (41-50 of 170) with videos related to

Sort By:
Pageof 17
American Journal of Medical Genetics. Part A|October 14, 2005
A novel mutation in the MSX2 gene in a family with foramina parietalia permagna (FPP)Liesbeth Spruijt, Pieter Verdyck, Wim Van Hul, et al.
The Journal of Biological Chemistry|December 21, 2002
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant proteinKatrien Janssens, Peter ten Dijke, Stuart H Ralston, et al.
Calcified Tissue International|November 25, 2019
WNT16 Requires Gα Subunits as Intracellular Partners for Both Its Canonical and Non-Canonical WNT Signalling Activity in OsteoblastsGretl Hendrickx, Eveline Boudin, Marinus Verbeek, et al.
Endocrine|April 29, 2009
Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variantsArmand Peeters, Sigri Beckers, An Verrijken, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 14, 2007
Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signalingWendy Balemans, Jean-Pierre Devogelaer, Erna Cleiren, et al.
Endocrine|October 26, 2010
Common melanocortin-3 receptor variants are not associated with obesity, although rs3746619 does influence weight in obese individualsDoreen Zegers, Sigri Beckers, Ilse L Mertens, et al.
Bone|April 9, 2013
No mutations in the serotonin related TPH1 and HTR1B genes in patients with monogenic sclerosing bone disordersEveline Boudin, Karen Jennes, Fenna de Freitas, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|October 23, 2008
Recurrent sclerosing dysplasia of bone: report of a caseMartin Druce Batstone, Gary Walton, Anthony Lynham, et al.
Molecular Genetics and Metabolism|April 5, 2011
Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in menDoreen Zegers, Sigri Beckers, Ilse L Mertens, et al.
Molecular and Cellular Biology|June 1, 2005
Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signalingMinrong Ai, Sheri L Holmen, Wim Van Hul, et al.
Pageof 17